Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leucogen
- Development stage
- Phase 3
- Lead developer
- Partner Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Leucogen is a small molecule cysteine derivative primarily utilized for the treatment and prevention of leukopenia and neutropenia, particularly those induced by chemotherapy or radiation therapy. It functions by stimulating the bone marrow to increase the production of white blood cells (WBCs) and platelets. Beyond its standard use in hematological recovery, Leucogen has been investigated as a prophylactic agent to mitigate the side effects of targeted therapies, such as Pralsetinib in patients with RET fusion-positive non-small cell lung cancer (NSCLC). It has also shown efficacy in treating thrombocytopenia and leukopenia associated with alcoholic liver cirrhosis. The drug is typically administered orally in tablet form.
- Brand names
- Leucogen
- Other names
- LeucogenumL-LeucogenLikejun2-acetylamino-4-mercapto-4-methyl-butyrolactone
Beyond the preview
Go deeper on Leucogen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leucogen.